<DOC>
	<DOCNO>NCT01812733</DOCNO>
	<brief_summary>The objective non-interventional study compare quality life , health care resource use cost use combination oxycodone naloxone ( Targiniq ) versus oxycodone laxatives patient severe pain , evaluate cost-effectiveness treatment Targiniq .</brief_summary>
	<brief_title>Non-interventional Study Comparing Targiniq Oxycodone/Laxatives</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Laxatives</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Inclusion criterion : Male nonpregnant female ≥18 year age Malignant nonmalignant opioid sensitive pain Must sign inform consent form ( ICF ) Must stable daily dose oxycodone prolonged release formulation titrate analgesic effect ( assessed clinical expert ) Use laxatives concomitant opioidinduced constipation adequate dose length time without sufficient effect BFI ≥30 state discomfort cause constipation screen Ability answer patient questionnaire estimate overall life expectancy least six ( 6 ) month Exclusion criterion : History , ongoing , abuse alcohol and/or drug Inability read understand write instruction , ICF questionnaires Constipation relate opioid use Unsuitable patient reason ( ) opinion investigator Inpatients , admission and/or discharge expect study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>